<DOC>
	<DOCNO>NCT02366052</DOCNO>
	<brief_summary>The main aim study determine oral supplementation LCS beneficial effect even enhance beneficial effect moderate life-style intervention progression NAFLD human .</brief_summary>
	<brief_title>Nutritional Counseling vs. Nutritional Supplements NASH - Randomized Prospective , Open Label Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Elevated M30 antigen level ( cutoff : &gt; 200 800 U/L ) screening AND hepatic steatosis ultrasound OR histologically confirm NASH Age 18 75 year Alcohol intake 30 g/d ( men ) 20 g/d ( woman ) Treatment ursodeoxycholic acid ( UDCA ) , Vitamin E investigational NASH drug 3 month prior randomization Treatment medication substance may induce secondary NASH ( e.g. , tamoxifen , corticosteroid , amiodarone , methotrexate ) ameliorate NASH ( TNFantagonists ) Treatment phenprocoumon warfarin Hepatocellular carcinoma nonhepatic malignancy Decompensated cirrhosis ( Child B , C ) history decompensation Liver disease unrelated NASH , include chronic viral hepatitis B/D C , autoimmune hepatitis , Wilson 's disease clinical manifest iron overload Bariatric surgery within last 5 year BMI &lt; 18,5 kg/m2 BMI &gt; 45 kg/m2 Liver transplantation Heart failure ( New York Heart Association Class II IV ) Myocardial infarction , instable coronary artery disease , coronary artery intervention stroke previous 6 month Instable chronic obstructive pulmonary disease , chronic inflammatory bowel disease rheumatoid arthritis . Instable renal insufficiency ( change serum creatinin &gt; 50 % last 3 month ) terminal renal insufficiency require dialysis Uncontrolled hypertension ( blood pressure &gt; 180/90 despite therapy ) Uncontrolled diabetes mellitus define hemoglobin A1c &gt; 9 Food allergy require strictly dietary adherence Pregnant nursing woman Chronic pancreatitis history recur acute pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Histologically confirm NASH</keyword>
	<keyword>Hepatocyte Injury determine M30 antigen</keyword>
</DOC>